HENDERSON MICHAEL THOMAS — SEC insider filings

SEC reporting owner CIK 1779990. 44 insider filings on record with FilingPulse; latest filed 2026-10-20.

Transaction summary — filings shown

Covers all 44 filings on record, filed 2020-08-18 to 2026-10-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Apogee Therapeutics, Inc. (APGE)Chief Executive Officer, Director26—50 legs · 505,000 sh · $37,957,49612
Spyre Therapeutics, Inc. (SYRE)Director7—5 legs · 100,000 sh · $7,952,0505
BridgeBio Pharma, Inc. (BBIO)Chief Business Officer9—11 legs · 60,784 sh · $2,447,98626
ARYA Sciences Acquisition Corp IV (ARYD)Director1——1
TCGX Acquisition Corp. II (TCXB)Director1———

Insider filings — HENDERSON MICHAEL THOMAS

FiledFormIssuerReported transactionsSource
2026-10-203TCGX Acquisition Corp. II (TCXB)Holdings only — no transactions reportedEDGAR
2026-09-034Apogee Therapeutics, Inc. (APGE)Disposition to issuer (D): 920,941 · Disposition to issuer (D): 387,012 (derivative) · Disposition to issuer (D): 357,036 (derivative) · Disposition to issuer (D): 253,016 (derivative)EDGAR
2026-07-104Apogee Therapeutics, Inc. (APGE)Sale (S): 20,000 @ $133.63 · Gift (G): 75,046 @ $0EDGAR
2026-06-244Apogee Therapeutics, Inc. (APGE)Sale (S): 80,000 @ $132.54EDGAR
2026-06-234Spyre Therapeutics, Inc. (SYRE)Sale (S): 20,000 @ $100EDGAR
2026-06-124Apogee Therapeutics, Inc. (APGE)Sale (S): 6,770 @ $82.21 · Sale (S): 7,654 @ $82.78 · Sale (S): 1,080 @ $84.18 · Sale (S): 1,577 @ $85.19 · Sale (S): 2,305 @ $86.27 · Sale (S): 614 @ $86.89EDGAR
2026-05-294Spyre Therapeutics, Inc. (SYRE)Grant/award (A): 8,026 (derivative) @ $0EDGAR
2026-05-154Apogee Therapeutics, Inc. (APGE)Sale (S): 18,659 @ $82.05 · Sale (S): 1,341 @ $82.58EDGAR
2026-05-084Spyre Therapeutics, Inc. (SYRE)Sale (S): 2,404 @ $72.57 · Sale (S): 33,513 @ $73.72 · Sale (S): 24,814 @ $74.76 · Sale (S): 19,269 @ $75.35EDGAR
2026-04-204Apogee Therapeutics, Inc. (APGE)Option exercise (M): 3,000 @ $22.86 · Option exercise (M): 3,000 (derivative) @ $0EDGAR
2026-04-104Apogee Therapeutics, Inc. (APGE)Sale (S): 17,800 @ $82.48 · Sale (S): 2,000 @ $83.26 · Sale (S): 200 @ $85EDGAR
2026-03-134Apogee Therapeutics, Inc. (APGE)Sale (S): 8,363 @ $74.29 · Sale (S): 8,219 @ $74.83 · Sale (S): 3,418 @ $75.86EDGAR
2026-02-134Apogee Therapeutics, Inc. (APGE)Sale (S): 11,494 @ $62.96 · Sale (S): 7,551 @ $63.73 · Sale (S): 955 @ $64.99EDGAR
2026-01-234Spyre Therapeutics, Inc. (SYRE)Other (J): 63,227 @ $0EDGAR
2026-01-164Apogee Therapeutics, Inc. (APGE)Sale (S): 1,440 @ $78.64 · Sale (S): 8,476 @ $79.82 · Sale (S): 2,374 @ $81 · Sale (S): 1,854 @ $82.41 · Sale (S): 5,386 @ $83.16 · Sale (S): 470 @ $83.79EDGAR
2026-01-064Apogee Therapeutics, Inc. (APGE)Grant/award (A): 253,016 (derivative) @ $0EDGAR
2025-12-124Apogee Therapeutics, Inc. (APGE)Sale (S): 9,435 @ $74.88 · Sale (S): 10,005 @ $75.79 · Sale (S): 560 @ $76.58EDGAR
2025-12-054Apogee Therapeutics, Inc. (APGE)Sale (S): 40,000 @ $75.01EDGAR
2025-11-134Apogee Therapeutics, Inc. (APGE)Sale (S): 3,340 @ $61.93 · Sale (S): 14,774 @ $63.14 · Sale (S): 1,786 @ $63.89 · Sale (S): 100 @ $64.52EDGAR
2025-06-024Spyre Therapeutics, Inc. (SYRE)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2025-03-074Apogee Therapeutics, Inc. (APGE)Sale (S): 7,326 @ $29.98 · Sale (S): 2,674 @ $30.62EDGAR
2025-02-074Apogee Therapeutics, Inc. (APGE)Sale (S): 15,000 @ $40.58EDGAR
2025-01-314Apogee Therapeutics, Inc. (APGE)Option exercise (M): 8,500 @ $22.86 · Option exercise (M): 8,500 (derivative) @ $0EDGAR
2025-01-144Spyre Therapeutics, Inc. (SYRE)Other (J): 105,379 @ $0EDGAR
2025-01-104Apogee Therapeutics, Inc. (APGE)Sale (S): 12,132 @ $48.72 · Sale (S): 2,868 @ $49.38EDGAR
2024-12-114Apogee Therapeutics, Inc. (APGE)Grant/award (A): 357,036 (derivative) @ $0EDGAR
2024-12-064Apogee Therapeutics, Inc. (APGE)Sale (S): 13,328 @ $46.50 · Sale (S): 1,672 @ $47.19EDGAR
2024-11-084Apogee Therapeutics, Inc. (APGE)Sale (S): 14,000 @ $59.17 · Sale (S): 1,000 @ $59.94EDGAR
2024-10-044Apogee Therapeutics, Inc. (APGE)Sale (S): 30,288 @ $56.07 · Sale (S): 9,712 @ $56.74EDGAR
2024-09-064Apogee Therapeutics, Inc. (APGE)Sale (S): 25,641 @ $47.28 · Sale (S): 14,359 @ $48.23EDGAR
2024-08-094Apogee Therapeutics, Inc. (APGE)Sale (S): 32,233 @ $40.40 · Sale (S): 7,667 @ $41.52 · Sale (S): 100 @ $42.17EDGAR
2024-07-314ARYA Sciences Acquisition Corp IV (ARYD)Disposition to issuer (D): 30,000 (derivative)EDGAR
2024-07-054Apogee Therapeutics, Inc. (APGE)Sale (S): 15,000 @ $37.26EDGAR
2024-05-164Spyre Therapeutics, Inc. (SYRE)Grant/award (A): 11,323 (derivative) @ $0EDGAR
2023-12-204Apogee Therapeutics, Inc. (APGE)Grant/award (A): 398,512 (derivative) @ $0EDGAR
2020-12-174BridgeBio Pharma, Inc. (BBIO)Grant/award (A): 4,456 (derivative) @ $0 · Grant/award (A): 3,137 (derivative) @ $0 · Grant/award (A): 2,199 (derivative) @ $0EDGAR
2020-12-024BridgeBio Pharma, Inc. (BBIO)Sale (S): 784 @ $30.04EDGAR
2020-12-024BridgeBio Pharma, Inc. (BBIO)Option exercise (M): 10,000 @ $1.05 · Sale (S): 3,028 @ $51.12 · Sale (S): 6,972 @ $51.69 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2020-11-184BridgeBio Pharma, Inc. (BBIO)Option exercise (M): 10,000 @ $1.05 · Sale (S): 10,000 @ $45 · Option exercise (M): 12,813 · Tax withholding (F): 6,353 @ $44.33 · Option exercise (M): 10,000 (derivative) @ $0 · Option exercise (M): 12,813 (derivative) @ $0EDGAR
2020-11-034BridgeBio Pharma, Inc. (BBIO)Option exercise (M): 10,000 @ $1.05 · Sale (S): 9,500 @ $38.33 · Sale (S): 500 @ $38.92 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2020-10-054BridgeBio Pharma, Inc. (BBIO)Option exercise (M): 3,255 @ $0.28 · Option exercise (M): 6,745 @ $1.05 · Sale (S): 4,495 @ $38.29 · Sale (S): 5,505 @ $39.28 · Option exercise (M): 2,236 (derivative) @ $0 · Option exercise (M): 1,019 (derivative) @ $0 · +1 moreEDGAR
2020-09-224BridgeBio Pharma, Inc. (BBIO)Option exercise (M): 4,901 @ $0.16 · Option exercise (M): 5,099 @ $0.28 · Sale (S): 10,000 @ $40 · Option exercise (M): 4,901 (derivative) @ $0 · Option exercise (M): 5,099 (derivative) @ $0EDGAR
2020-09-034BridgeBio Pharma, Inc. (BBIO)Option exercise (M): 10,000 @ $0.16 · Sale (S): 5,022 @ $27.89 · Sale (S): 4,978 @ $29.58 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2020-08-184BridgeBio Pharma, Inc. (BBIO)Option exercise (M): 12,812 · Tax withholding (F): 5,460 @ $28.53 · Option exercise (M): 12,812 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1779990 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs